A recall of insulin pumps manufactured by device giant Medtronic plc has brought additional trouble to the company, which on 15 December announced that it has received a warning letter from the US Food and Drug Administration tied to a recent inspection of the firm’s diabetes business headquarters.
The inspection of the Northridge, CA, facility concluded in July 2021 and was related to expanded recalls of the MiniMed...